A total of 7,190 blood culture sets were obtained from adult patients with a suspected bloodstream infection. A 20-ml sample of blood was distributed equally between the aerobic FAN bottle which was monitored in the BacT/Alert system and a Plus Aerobic/F bottle which was monitored in the BACTEC 9240 system. A total of 988 positive cultures were obtained from 483 patients; however, only 453 positive cultures from 173 patients met the criteria for volume (>8 ml per bottle) and clinical significance on the basis of concurrent case review required for data analysis. There were 25 and 68 false positives from the FAN and Plus Aerobic/F bottles, respectively. There were no statistically significant differences between systems in the number of positive cultures or septic episodes by species; however, the total number of Enterobacteriaceae and Pseudomonas aeruginosa isolates combined was significantly greater in the FAN bottle (P ‫؍‬ 0.04). Detection times did not differ significantly between systems for positive cultures; however, episodes of Staphylococcus aureus bacteremia were detected significantly more rapidly from the FAN bottle (P ‫؍‬ 0.005). There was no significant difference between systems in the detection of bloodstream infections in patients receiving antibiotics at the time of blood culture.
The aerobic FAN blood culture bottle (Organon Teknika Corporation, Durham, N.C.) is a newly formulated medium consisting of brain heart infusion broth containing a patented compound, Ecosorb, which consists of activated carbon and Fuller's earth. The bottle is monitored for the development of microbial growth in the BacT/Alert blood culture system. In a recent study by Weinstein et al. (13) , there were more positive cultures with clinically significant isolates of Staphylococcus aureus, coagulase-negative staphylococci, yeasts, and all organisms combined recovered from the aerobic FAN bottle than from the standard aerobic bottle in the BacT/Alert system (this finding was statistically significant). These investigators also observed an increased yield of staphylococci from the FAN bottle from the cultures obtained from patients receiving antimicrobial therapy.
Since the recovery of bacteria, particularly in the presence of antibiotics, has been shown to be enhanced by the use of resins in blood cultures (1) (2) (3) (4) (7) (8) (9) (10) (11) (12) , we decided to conduct a controlled clinical study comparing the performance of the aerobic FAN and BACTEC Plus Aerobic/F (Becton Dickinson Instrument Systems, Sparks, Md.) bottles for the detection of bloodstream infections.
MATERIALS AND METHODS
The study was conducted between November 1994 and February 1995. Blood was drawn aseptically from all adult inpatients and outpatients with suspected bloodstream infections and inoculated directly into each bottle by phlebotomists or, in the case of patients with central venous access lines and no peripheral venous access, by nursing personnel as instructed by laboratory personnel. As a matter of policy, a second blood culture was obtained, if possible, when only a single blood culture had been ordered. A total of 20 ml of blood was obtained aseptically and distributed equally at bedside between the aerobic FAN bottle and the Plus Aerobic/F bottle. No blood was collected specifically for anaerobic culture, since prior data from this laboratory over the past decade have shown that anaerobic bacteremia has occurred in less than 1% of bloodstream infections, even when anaerobic cultures have been performed on a selective basis with patients on the colorectal and gynecological surgical services (unpublished epidemiologic data). During the first half of the study, the Plus Aerobic/F bottle was inoculated first; this sequence was reversed approximately halfway through the study. On arrival in the laboratory, the bottles were checked for volume of blood by comparison of the blood-broth column height with that of bottles prefilled with known volumes of broth.
The FAN and Plus Aerobic/F bottles were incubated at 35ЊC for 5 days in their respective incubator modules. Plus Aerobic/F bottles received between 11 p.m. and 7 a.m. were stored at room temperature, whereas FAN bottles were incubated at 35ЊC in stationary fashion according to each manufacturer's directions. Bottles with positive signals were routinely removed, and aliquots of the broth were Gram stained and subcultured aerobically and anaerobically between the hours of 7 a.m. and 11 p.m. All bottles without detectable growth were subcultured terminally on chocolate and blood agar plates which were incubated aerobically and anaerobically, respectively, at 35ЊC for 48 h. False-positive bottles (i.e., instrument positive but Gram stain and aerobic and anaerobic subculture negative) were reincubated and, if still negative at the end of the fifth day of incubation, were also terminally subcultured.
The clinical significance of isolates was assessed at the time of the positive culture by chart review and/or consultation with the patient's physician. Decisions were also made in accordance with the definitions published by the Centers for Disease Control and Prevention (5). The isolates were classified as representing sepsis, as contaminants, or as being of indeterminate clinical significance. Specific notation was made as to whether or not the patient was receiving antimicrobial therapy at the time of blood culture.
The statistical analysis was limited to those isolates that were classified as being clinically significant and that were recovered from cultures meeting the criterion of having a minimum of 8 ml in each component of the culture set. An additional analysis was made of clinically significant positive cultures from blood culture sets in which each component of the set contained at least 6 ml of blood. Isolates not meeting these criteria were excluded from the analysis. Statistical analyses were carried out by methods described by Ilstrup (6) . The sign test for matched pairs was used to test for differences between the FAN and the Plus Aerobic/F bottles. Since many patients had more than one culture pair and the sign test assumes each pair to be from a different patient, an alternative analysis, whereby the analysis set was defined on the basis of a septic episode instead of all positive cultures, was used. A septic episode was defined as the initial isolation of a clinically significant organism, the subsequent isolation of a different clinically significant organism, or the isolation of the same organism after an interval of at least 5 days since the last positive culture. These data sets were also analyzed with the sign test to compare the isolation rates for the systems. Assuming that the isolation of a particular organism or organism group from either bottle denoted a true positive, the test sensitivity and 95% confidence intervals (CI) were calculated for each system. The sensitivity or true-positive rate was defined as the proportion of patients who had a positive result from a particular blood culture system.
RESULTS AND DISCUSSION
A total of 7,190 blood cultures were received during the study period. Of these, there were 25 and 68 false-positive cultures by the FAN and Plus Aerobic/F bottles, respectively. A total of 988 positive cultures were obtained from 433 patients; however, only 453 positive cultures from 173 patients met the inclusion criteria of clinically significant bloodstream infection and organism recovery from cultures in which each bottle contained at least 8 ml of blood. A total of 301 positive cultures failed to meet the 8-ml volume criterion. Another 234 positive cultures were excluded because the organisms isolated from them were considered to be of either indeterminate or no clinical significance. Of these cultures, 159 (67.9%) were cultures yielding Staphylococcus epidermidis and other coagulasenegative staphylococci. Over 63% (109 of 173) of the patients were receiving antimicrobial agents at the time of blood culture; the use of antimicrobial therapy was unknown in 12% (20 of 173) of the patients. The remaining 44 (25%) of patients were not receiving antimicrobial therapy at the time of blood culture. Table 1 displays the number of clinically significant positive cultures by system. There were no significant differences in the number of positive cultures between systems either by organism group or by species ( Table 1) . The trend towards more frequent isolation of gram-negative bacilli in the FAN bottle became statistically significant only if all positive cultures with members of the family Enterobacteriaceae and Pseudomonas aeruginosa were combined (P ϭ 0.04). The data were also examined on the basis of the inoculation of each bottle with at least 6 ml of blood. Again, there were no significant differences in the number of positive cultures between systems by organism group or species. At this lower inoculum per bottle, there was a trend towards more positive cultures of gram-negative bacilli (P ϭ 0.06) and of Enterobacteriaceae (P ϭ 0.07) in the FAN bottle (data not shown). Once again, the Enterobacteriaceae and P. aeruginosa combined were still recovered significantly more frequently from the FAN bottle (P ϭ 0.03) (data not shown). The estimated sensitivities and 95% CI of the neoformans, and 1 S. epidermidis isolate from the Plus Aerobic/F bottle. There were no statistically significant differences between systems by species causing septic episodes in bottles inoculated with at least 8 ml of blood, and the trend towards more frequent detection of septic episodes due to the aggregate of Enterobacteriaceae and P. aeruginosa did not achieve statistical significance (P ϭ 0.06) (data not shown). Mean and median times for the detection of organisms did not differ significantly between systems except for S. aureus (Table 2) . In this instance, there were 78 positive cultures in both bottles from 34 patients. By examining the difference in detection time (in days) between systems for each of the 34 patients, the Wilcoxon matched-pairs signed-rank test demonstrated a significantly faster detection time for the FAN bottle (P ϭ 0.005). Finally, when the data were analyzed on the basis of those patients receiving antimicrobial therapy at the time of blood culture, there was no significant difference between systems.
In conclusion, the two bottles were comparable in all respects, except for the trend towards more frequent isolation of S. epidermidis from the Plus Aerobic/F bottle and the trend towards more frequent isolation of gram-negative bacilli and especially the aggregate of Enterobacteriaceae and P. aeruginosa from the FAN bottle. To what extent the latter trend may have been influenced by the difference in the volume of broth (25 ml in the BACTEC bottle and 40 ml in the BacT/Alert bottle) and the resulting lesser dilution in the BACTEC bottle is not known. This study compared only the aerobic components of each blood culture system and obviously does not reflect the overall performance of a two-bottle BACTEC or BacT/Alert system in which the second bottle would provide an anaerobic incubation environment with or without supplements that neutralize antimicrobial agents. 
